We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

1 hedge funds and large institutions have $0 invested in Tetraphase Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% less funds holding

Funds holding: 26 → 1 (-25)

100% less capital invested

Capital invested by funds: $5.69M → $0 (-$5.69M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 25

Holders
1
Holders Change
-25
Holders Change %
-96.15%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$3.58M
2
Renaissance Technologies
Renaissance Technologies
New York
-$552K
3
CH
CVI Holdings
Delaware
-$524K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$197K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$175K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
– -$3.58M -1,419,507 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
– -$552K -219,140 Closed
CH
3
CVI Holdings
Delaware
– -$524K -208,074 Closed
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
– -$197K -78,218 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$175K -69,402 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$161K -64,092 Closed
BlackRock
7
BlackRock
New York
– -$138K -54,721 Closed
TCM
8
Tekla Capital Management
Massachusetts
– -$108K -42,965 Closed
BCM
9
Bridgeway Capital Management
Texas
– -$76K -30,000 Closed
Bank of New York Mellon
10
Bank of New York Mellon
New York
– -$58K -23,117 Closed
Bank of America
11
Bank of America
North Carolina
– -$37K -14,730 Closed
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
– -$32K -12,664 Closed
Northern Trust
13
Northern Trust
Illinois
– -$25K -10,043 Closed
JP Morgan Chase
14
JP Morgan Chase
New York
– -$13K -5,069 Closed
UBS Group
15
UBS Group
Switzerland
– -$7K -2,925 Closed
SBL
16
Sargent Bickham Lagudis
Colorado
– -$3K -1,000 Closed
Group One Trading
17
Group One Trading
Illinois
– -$2K -601 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$1K -506 Closed

TTPH Hedge Fund Activity: Q3 2020 in Review

1 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2020, worth a combined $0 — down 100% from $5.69M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of TTPH and 0 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Armistice Capital, exiting entirely with an estimated $3.58M sold.

  • 1 institutional investor held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2020, down from 26 in Q2 2020.
  • Funds reported $0 of Tetraphase Pharmaceuticals, Inc. stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2020 and 25 closed out, a net change of -25 holders.
  • The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2020 was Armistice Capital, an estimated $3.58M sold.

Based on aggregated 13F filings for Q3 2020.